Intraoperative OCT-Assisted Gene Therapy

Intraoperative OCT Augments Surgical Safety and Accuracy of Treatment Delivery in Subretinal Gene Augmentation Therapy

Gene augmentation therapy is a method of ocular gene transfer for autosomal recessive or X-linked retinal dystrophies when there is insufficient functional protein manifesting as genetic disease. These genetic defects cause specific visual impairments and/or retinal degeneration. There has been a recent explosion in interest in gene therapy applications for retinal dystrophies. The surgical technique for subretinal injection of gene therapy is technically demanding and challenging. Intraoperative optical coherence tomography (Intraoperative OCT) provides real-time information and surgeon feedback about depth of penetration into posterior segment structures, the distribution and propagation of injected fluid, vector reflux, and the integrity of the fovea during the procedures.  


Topics & Tags

Download the full White Paper

Want to learn more about the surgical techniques for subretinal injection of gene therapy for retinal dystrophies? Enter your information to download the full white paper.

Download Whitepaper

By clicking on the SUBMIT button, I confirm that I have reviewed and agree with Leica Microsystems GmbH Terms of Use and their Privacy Policy. I also understand my privacy choices as they pertain to my personal data, as detailed in the aforementioned Privacy Policy under ‘’Your Privacy Choices’’.

Interested to know more?

Talk to our experts. We are happy to answer all your questions and concerns.

Contact Us

Do you prefer personal consulting?

  • Leica Microsystems Inc.
    1700 Leider Lane
    Buffalo Grove, IL 60089 United States
    Office Phone : +1 800 248 0123
    Service Phone : 1 800 248 0223
    Fax : +1 847-236-3009

You will find a more detailed list of local contacts here.